Scholars Central

Research articlePublished 27 Mar 2015

2-Substituted-5-(5-nitro-furan-2-yl)-1,3,4-thiadiazoles: Anti-Helicobacter pylori activity evaluation and docking study

Authors: Farhad Alvandifar, Azar Tahghighi, Reyhaneh Sabourian, Loghman Firoozpour, Mohammad Mahdavi, Parastoo Saniee, Najme Edraki, Mohammad Hassan Moshafi, Abbas Shafiee, Alireza Foroumadi

Journal of Chemical and Pharmaceutical Research

Volume 7 · Issue 3 · Pages 2512–2519

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Helicobacter pylori causes gastric and gastroduodenal ulcer disease and chronic infection of H. pylori is attributed to adenocarcinoma. 2-Substituted-5-(nitro-aryl)-1,3,4-thiadiazoles are being extensive evaluated against H. pylori isolates. In this study, a series of 2-Substituted-5-(5-nitro-furan-2-yl)-1,3,4-thiadiazoles selected and evaluated for anti-Helicobacter pylori activity. Molecular docking simulation on H. pylori urease active site improves showed potential interaction between selected ligands and H. pylori urease. In this study in vitro anti-Helicobacter pylori assay was evaluated for some selected 5-(5-nitrofuran-2-yl)-1,3,4-thiadiazole containing compounds. Docking simulation for designed compound was performed to explain mechanism of interactions. It was found that most compounds exhibited significant anti-Helicobacter pylori activity more potent than the standard drug metronidazole. In vitro anti-Helicobacter pylori activity was performed that 2-(5-(5-nitrofuran-2-yl)-1,3,4- thiadiazol-2-ylthio)-N-propylacetamide was the most potent compound among all tested compounds against clinical isolates of H. pylori. Development of new 5-(5-nitrofuran-2-yl)-1,3,4-thiadiazol derivatives containing thio-linker (N-(alkyl) acetamides) as potentially potent anti-Helicobacter pylori agents is greatly suggested.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Chemical and Pharmaceutical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Chemical and Pharmaceutical Research
  • SubjectPharmaceutical Sciences
  • SubjectChemistry
  • BylineArticles whose byline prints “Farhad Alvandifar”
  • BylineArticles whose byline prints “Azar Tahghighi”
  • BylineArticles whose byline prints “Reyhaneh Sabourian”
  • BylineArticles whose byline prints “Loghman Firoozpour”
  • BylineArticles whose byline prints “Mohammad Mahdavi”
  • BylineArticles whose byline prints “Parastoo Saniee”
  • BylineArticles whose byline prints “Najme Edraki”
  • BylineArticles whose byline prints “Mohammad Hassan Moshafi”